Company and Competitor Profile: West Houston Clinical Research Service, LLC
Overview
West Houston Clinical Research Service, LLC is a prominent clinical research organization headquartered in Houston, Texas, established in 2007. The company is dedicated to delivering high-quality research data for pharmaceuticals through various phases of clinical trials, focusing on early-phase trials and specialized patient populations such as asthmatics, geriatrics, and hypertensives. The facility’s strategic location at 2026 Wirt Road, Houston, Texas 77055 supports its operations and patient recruitment efforts.
Key Financials and Operations
- Annual Revenue: Estimated between $1 million and $5 million.
- Employee Size: Approximately 11-20 employees, indicative of a specialized and focused workforce.
- Headquarters: Houston, Texas.
Leadership
The leadership of West Houston Clinical Research Service is under the direction of Braulio Suarez, the Clinical Research Director. His role is pivotal in driving the company's research initiatives and ensuring that clinical trials align with pharmaceutical industry needs.
Services and Capabilities
West Houston Clinical Research Service offers comprehensive services across Phase I, II, and III clinical trials. The organization specializes in an array of therapeutic areas, including:
- Analgesia
- Cardiovascular
- Central Nervous System (CNS)
- Dermatology
- Endocrinology
- Infectious Diseases
- Respiratory
The facility also supports diverse routes of administration, including intravenous (IV), intramuscular (IM), subcutaneous injections, inhalant, oral, and topical delivery methods.
Research and Development
The company's research efforts encompass both pharmacokinetic and pharmacodynamic studies, providing deep insights into drug behaviors in varied populations. West Houston Clinical Research Service is equipped with facilities to handle both outpatient care and specialized Phase I research, with a building capable of housing up to 40 patients.
Contact Details
For inquiries and potential collaborations, contact:
- Phone: +1 281-738-2642
- Email: bsuarez@whcrs.com
- Website: [whcrs.com](http://www.whcrs.com)
Competitor Analysis
West Houston Clinical Research Service contends with several key competitors within the clinical research industry, each providing significant offerings in early-phase trials:
- Celerion: Known for excellence in early clinical research and translational medicine, providing global services with robust clinical and bio-analytical capabilities.
- Altasciences: Offers flexible models for preclinical and clinical pharmacology studies with an integrated service model suitable for pharmaceutical and biotech companies.
- AskGene Pharma: Specializes in cytokine therapeutics with their innovative SmartKine® platform offering advanced biologic solutions.
Strategic Positioning and Advantages
West Houston Clinical Research Service carves a competitive space by focusing on early-phase trials specifically designed for unmet needs in patient demographics. Their Houston base facilitates strategic geographic access to a diverse patient population, optimizing trial recruitment and execution. By concentrating on select patient groups, the company enhances niche expertise, potentially speeding up trial timelines and refining data relevance for targeted therapies.
Key Considerations for Engagement
- Specialization: Emphasizing West Houston's expertise in specialized demographics can attract partnerships focused on targeted therapeutic areas.
- Geographic Benefit: The strategic location in Houston aids in tapping diverse patient groups, optimizing logistical aspects of patient recruitment.
- Collaborative Opportunities: Potential partnerships with entities like Celerion or Altasciences might offer shared expertise and capabilities, boosting innovation and service reach.
Leveraging these strategic insights helps West Houston Clinical Research Service sustain its advantage within the clinical trials domain.
